Accessibility StatementSkip Navigation MARLBOROUGH, Mass., Oct. 22, 2025 /PRNewswire/ --Â Boston Scientific Corporation (NYSE:Â BSX) generated net sales of $5.065 billion during the third quarter of 2025, growing 20.3 percent on a reported basis, 19.4 percent on an operational basis and 15.3 percent on an organic basis, all compared to the prior year period. The company reported GAAP net income attributable to Boston Scientific common stockholders of $755 million or $0.51 per share (EPS), compared to $469 m ...